Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2

被引：122

作者：

Vihola, A

Bassez, G

Meola, G

Zhang, S

Haapasalo, H

Paetau, A

Mancinelli, E

Rouche, A

Hogrel, JY

Laforêt, P

Maisonobe, T

Pellissier, JF

Krahe, R

Eymard, B

Udd, B ^{[1
]}

机构：

[1] Vaasa Cent Hosp, Dept Neurol, FIN-65130 Vaasa, Finland

[2] Salpetriere Hosp, Myol Inst, Paris, France

[3] Univ Milan, San Donato Hosp, Dept Neurol, Milan, Italy

[4] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA

[5] Tampere Univ Hosp, Dept Pathol, Tampere, Finland

[6] Univ Helsinki, Dept Pathol, FIN-00014 Helsinki, Finland

[7] Univ Milan, Dept Physiol & Gen Biochem, I-20122 Milan, Italy

[8] Salpetriere Hosp, Dept Neuropathol, Paris, France

[9] Hop Enfants La Timone, Dept Pathol & Neuropathol, Marseille, France

[10] Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA

来源：

NEUROLOGY | 2003年 / 60卷 / 11期

关键词：

D O I：

10.1212/01.WNL.0000065898.61358.09

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Muscle biopsy findings in DM2 have been reported to be similar to those in DM1. The authors used myosin heavy chain immunohistochemistry and enzyme histochemistry for fiber type differentiation on muscle biopsies. Their results show that DM2 patients display a subpopulation of type 2 nuclear clump and other very small fibers and, hence, preferential type 2 fiber atrophy in contrast to type 1 fiber atrophy in DM1 patients.

引用

页码：1854 / 1857

页数：4

共 50 条

[21] Increased K+ release during exercise in myotonic dystrophy type 1 (DMl) but not type 2 (DM2, PROMM)
Hanisch, F.
Eger, K.
Hart, H.
Scharf, A.
Kornhuber, M.
Zierz, S.
NEUROMUSCULAR DISORDERS, 2006, 16 (9-10) : 671 - 671
[22] Gene expression analysis in myotonic dystrophy: Indications for a common molecular pathogenic pathway in DM1 and DM2
Botta, Annalisa
Vallo, Laura
Rinaldi, Fabrizio
Bonifazi, Emanuela
Amati, Francesca
Biancolella, Michela
Gambardella, Stefano
Mancinelli, Enzo
Angelini, Corrado
Meola, Giovanni
Novelli, Giuseppe
GENE EXPRESSION, 2007, 13 (06): : 339 - 351
[23] Health-related quality of life in myotonic dystrophy type 1 (DM1) and type 2 (DM2): Correlations with indexes of cognitive and behavioral abnormalities
Sansone, V
Gandossini, S
Cotelli, M
Calabria, M
Zanetti, O
Apolone, G
Meola, G
NEUROLOGY, 2006, 66 (05) : A151 - A152
[24] Myotonic dystrophy type 1 (DM1) infant and autism spectrum
不详
M S-MEDECINE SCIENCES, 2015, 31 : 33 - 33
[25] Transgenic mouse models for myotonic dystrophy type 1 (DM1)
Wansink, DG
Wieringa, B
CYTOGENETIC AND GENOME RESEARCH, 2003, 100 (1-4) : 230 - 242
[26] Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2)
Sergio Salvatori
Sandra Furlan
Marina Fanin
Anne Picard
Ebe Pastorello
Vincenzo Romeo
Carlo Pietro Trevisan
Corrado Angelini
Neurological Sciences, 2009, 30 : 185 - 192
[27] Predictors of dysphagia and aspiration in myotonic dystrophy type 1 (DM1)
Allen, J.
Ramdharry, G.
Astin, R.
Turner, C.
Smith, C.
NEUROMUSCULAR DISORDERS, 2021, 31 : S119 - S119
[28] Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2)
Salvatori, Sergio
Furlan, Sandra
Fanin, Marina
Picard, Anne
Pastorello, Ebe
Romeo, Vincenzo
Trevisan, Carlo Pietro
Angelini, Corrado
NEUROLOGICAL SCIENCES, 2009, 30 (03) : 185 - 192
[29] Neuropsychological profile in Myotonic Dystrophy (DM1)
Sistiaga, Andone
Maria Cobo, Ana
Otaegui, David
Blanco, Ana
Jodar, Merce
Lopez de Munain, Adolfo
NEUROMUSCULAR DISORDERS, 2006, 16 : S138 - S138
[30] Understanding dysphagia in patients living with myotonic dystrophy type 1 (DM1)
Allen, J.
Ramdharry, G.
Astin, R.
Turner, C.
Smith, C.
NEUROMUSCULAR DISORDERS, 2021, 31 : S119 - S120

← 1 2 3 4 5 →